Clinical Trial Update: A Global Active Surveillance for Community Acquired Pneumonia [NA]

View source ↗

Summary

Pfizer-sponsored global active surveillance trial for community-acquired pneumonia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Snippet

Sponsor: Pfizer | Conditions: Community Acquired Pneumonia | NA | Status: COMPLETED